Evogene Ltd. EVGN

$ 1.83 -5.26%

Annual report 2023
added 10-19-2024

Evogene Ltd. Balance Sheet 2011-2024 | EVGN

Annual Balance Sheet Evogene Ltd.

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-	-	-	-3.44 M	-3.24 M	-10.2 M	-5.21 M	-95.5 M	-24.3 M	-
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	853 K	884 K	974 K	777 K	895 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	5.36 M	5.42 M	2.96 M	3.56 M	3.47 M	3.2 M	3.58 M	3.99 M	7.1 M	-
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	15 M	11.1 M	8.39 M	8.22 M	8.7 M	8.84 M	11.5 M	12.6 M	16.6 M	-
Deferred Revenue	-	-	-	119 K	386 K	412 K	516 K	967 K	560 K	1.51 M	1.57 M	4.94 M	-
Retained Earnings	-	-	-	-179 M	-156 M	-138 M	-117 M	-96.2 M	-76.6 M	-59.4 M	-44.9 M	-36 M	-
Total Assets	51.1 M	56.1 M	76.3 M	71.9 M	71.4 M	58.7 M	77.6 M	96 M	113 M	128 M	137 M	64.9 M	-
Cash and Cash Equivalents	20.8 M	29 M	32.3 M	46.2 M	34.7 M	5.81 M	3.44 M	3.24 M	10.2 M	-	-	-	-
Book Value	-	-	76.3 M	56.9 M	60.2 M	50.3 M	69.4 M	87.3 M	104 M	116 M	125 M	48.3 M	-
Total Shareholders Equity	-	-	-	56.9 M	60.2 M	50.3 M	69.4 M	87.3 M	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Evogene Ltd.

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	1.7 M	-	1.6 M	-	1.66 M	-	1.79 M	-	2.08 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	6 M	-	5.57 M	-	5.36 M	-	5.31 M	-	5.4 M	-	-	-	2.96 M	-	-	-	3.56 M	-	-	-	3.47 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-	-207 M	-	-192 M	-	-179 M	-	-166 M	-	-156 M	-	-	-	-138 M	-	-	-	-117 M	-	-	-	-96.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	-	76.3 M	-	87.5 M	-	71.9 M	-	61.1 M	-	71.4 M	-	-	-	58.7 M	-	-	-	77.6 M	-	-	-	96 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	-	32.3 M	-	42.8 M	-	46.2 M	-	31.1 M	-	34.7 M	-	14.1 M	-	5.81 M	-	-	-	3.44 M	-	-	-	3.24 M	-	-	-	10.2 M	-	-	-	5.21 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	-	76.3 M	-	87.5 M	-	71.9 M	-	61.1 M	-	71.4 M	-	-	-	58.7 M	-	-	-	77.6 M	-	-	-	96 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	-	63.4 M	-	76.6 M	-	56.9 M	-	51 M	-	60.2 M	-	42.9 M	-	50.3 M	-	-	-	69.4 M	-	-	-	87.3 M	-	-	-	104 M	-	-	-	116 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency